MicroRNA therapeutics: principles, expectations, and challenges
about
Molecular biology of lung cancer: clinical implicationsThe insights of Let-7 miRNAs in oncogenesis and stem cell potencymiRNA Deregulation in Cancer Cells and the Tumor MicroenvironmentPrinciples of microRNA involvement in human cancers.The expression and functions of microRNAs in pancreatic adenocarcinoma and hepatocellular carcinomaA combined array-based comparative genomic hybridization and functional library screening approach identifies mir-30d as an oncomir in cancer.Mechanisms of miRNA-Mediated Gene Regulation from Common Downregulation to mRNA-Specific Upregulation.MiR-506 suppresses proliferation and induces senescence by directly targeting the CDK4/6-FOXM1 axis in ovarian cancer.MicroRNA-17, 20a regulates the proangiogenic function of tumor-associated macrophages via targeting hypoxia-inducible factor 2αLet-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathwayInhibition of mTOR sensitizes breast cancer stem cells to radiation-induced repression of self-renewal through the regulation of MnSOD and Akt.Dicer and microRNA expression in multiple sclerosis and response to interferon therapy.Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancerPost-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions.Expression of miR-125b in the new, highly invasive glioma stem cell and progenitor cell line SU3.Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung CancerAn interview with David H Farb, Section Editor for Basic Pharmacology.Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis.RNA interference-based therapy and its delivery systems.Non-Viral Based miR Delivery and Recent Developments.
P2860
Q24610335-BBB652C6-24BA-449A-838F-AEBA541BD5C2Q26751493-F9EAD000-6EF5-495C-824C-470BC291BEC6Q27025496-1C897503-E254-41E2-9D52-766BCB11AA42Q33579255-278F421B-FB7A-4EC4-811A-CA86923DD8B7Q33579675-0D9BC3FE-F107-4CED-980A-28DF9D34282FQ33913919-3481148F-35F1-416F-BC79-534F4B559D93Q34080540-0D816C34-33F6-410A-B6A7-CB51DDD5A3D8Q34089034-CD2A8D99-0546-4B00-9CCC-BC013D9C2B32Q35032481-CC46EEA1-BA6C-40DB-A116-18DA7D6EA952Q36184892-480113A0-7DFA-428F-BE70-9DF116EF8726Q36473698-2975001C-0F6D-43E0-AAC4-BEFCD382CE86Q36655150-7F2A5E71-3300-40BD-95F3-4DD85B63F81BQ36702185-1E77D40A-4E98-4709-8A7E-E082C1371EB3Q37681322-CB81E220-13C0-4831-990C-8B851F137DE9Q39391371-758057B2-39C7-4EC6-A9C5-363FD47E4810Q41552614-AE78F217-7666-4BDE-AA98-27CED1037DD8Q42855499-D18BC909-71AE-4412-9D20-1B1963DB069DQ44027685-FC56E967-2888-4D71-925E-98F97FBC779DQ47565462-57F2CF0D-B5C4-403D-84D0-D1E27D6C6921Q54231141-23E30EA4-17EB-4106-BD73-EE96FFCAD565
P2860
MicroRNA therapeutics: principles, expectations, and challenges
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
MicroRNA therapeutics: principles, expectations, and challenges
@en
MicroRNA therapeutics: principles, expectations, and challenges
@nl
type
label
MicroRNA therapeutics: principles, expectations, and challenges
@en
MicroRNA therapeutics: principles, expectations, and challenges
@nl
prefLabel
MicroRNA therapeutics: principles, expectations, and challenges
@en
MicroRNA therapeutics: principles, expectations, and challenges
@nl
P2093
P2860
P356
P1476
MicroRNA therapeutics: principles, expectations, and challenges
@en
P2093
Anil K Sood
Gabriel Lopez-Berestein
Hee-Dong Han
Rajesha Rupaimoole
P2860
P304
P356
10.5732/CJC.011.10186
P577
2011-06-01T00:00:00Z